VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by Retiremesouthon Feb 03, 2021 6:22pm

266 Views

Post# 32465804

For the Newbies

EXPLORE VMS+ 3.0 | Ventripoint

For the new investors out there it helps to know what you are buying in to. This cutting edge tech will change the way specialists gather data when it comes to your heart. No need to wait for lengthy MRI appointents that are sometimes months away due to backlogs. Cardiologists can have these in their office, get you hooked up and have your results that are equal to MRI all within the same appointment.

So does this tech have value? You bet it does! The faster a patient's heart can be analyzed the quicker the appropriate therapy can be applied.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale